| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Astragalosides | Breast Cancer | 8 | PM | 38193000 | 📋 | Astragaloside IV enhances the sensitivity of breast cancer stem cells to paclitaxel by inhibiting stemness |
| Astragalosides | Breast Cancer | 7 | PM | 37866315 | 📋 | Combination of oxymatrine (Om) and astragaloside IV (As) enhances the infiltration and function of TILs in triple-negative breast cancer (TNBC) |
| Astragalosides | Breast Cancer | 6 | PM | 37633006 | 📋 | Astragaloside IV antagonizes the malignant progression of breast cancer induced by macrophage M2 polarization through the TGF-β-regulated Akt/Foxo1 pathway |
| Astragalosides | Breast Cancer | 4 | PM | 33219447 | 📋 | Astragaloside IV inhibits cell proliferation and metastasis of breast cancer via promoting the long noncoding RNA TRHDE-AS1 |
| Astragalosides | Breast Cancer | 5 | PM | 32595723 | 📋 | Study on the Anticancer Effect of an Astragaloside- and Chlorogenic Acid-Containing Herbal Medicine (RLT-03) in Breast Cancer |
| Astragalosides | Breast Cancer | 3 | PM | 31762993 | 📋 | Effects of Astragaloside IV on Treatment of Breast Cancer Cells Execute Possibly Through Regulation of Nrf2 via PI3K/AKT/mTOR Signaling Pathway |
| Astragalosides | Breast Cancer | 1 | PM | 30146689 | 📋 | Astragaloside IV Enhances Taxol Chemosensitivity of Breast Cancer via caveolin-1-targeting Oxidant Damage |
| Astragalosides | Breast Cancer | 2 | PM | 27930970 | 📋 | Astragaloside IV Inhibits Breast Cancer Cell Invasion by Suppressing Vav3 Mediated Rac1/MAPK Signaling |
| Astragalosides | Cervical Cancer | 3 | PM | 37081108 | 📋 | Astragaloside IV suppresses the migration and EMT progression of cervical cancer cells by inhibiting macrophage M2 polarization through TGFβ/Smad2/3 signaling |
| Astragalosides | Cervical Cancer | 2 | PM | 32265995 | 📋 | Quantitative proteomics analysis of differentially expressed proteins induced by astragaloside IV in cervical cancer cell invasion |
| Astragalosides | Cervical Cancer | 1 | PM | 30896841 | 📋 | Astragaloside IV Inhibits the Invasion and Metastasis of SiHa Cervical Cancer Cells via the TGF‑β1‑mediated PI3K and MAPK Pathways |
| Astragalosides | Endometritis | 1 | PM | 30669661 | 📋 | Protective Effects of Astragaloside IV Against LPS-Induced Endometritis in Mice Through Inhibiting Activation of the NF-κB, p38 and JNK Signaling Pathways |
| Astragalosides | Gestational Diabetes | 3 | PM | 33006955 | 📋 | Astragaloside IV alleviates placental oxidative stress and inflammation in GDM mice |
| Astragalosides | Gestational Diabetes | 2 | PM | 32160476 | 📋 | Astragaloside IV Relieves Gestational Diabetes Mellitus in Genetic Mice Through Reducing Hepatic Gluconeogenesis |
| Astragalosides | Gestational Diabetes | 1 | PM | 31558153 | 📋 | Astragaloside IV Attenuates Gestational Diabetes Mellitus via Targeting NLRP3 Inflammasome in Genetic Mice |
| Astragalosides | Ovarian Cancer | 2 | PM | 37323083 | 📋 | Astragaloside II enhanced sensitivity of ovarian cancer cells to cisplatin via triggering apoptosis and autophagy |
| Astragalosides | Ovarian Cancer | 1 | PM | 33308900 | 📋 | Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis |
| Astragalosides | Polycystic Ovary Syndrome | 1 | PM | 36033957 | 📋 | Astragaloside IV regulates autophagy-mediated proliferation and apoptosis in a rat model of PCOS by activating the PPARγ pathway |
| Astragalosides | Preeclampsia | 2 | PM | 33089927 | 📋 | Astragaloside IV alleviates lipopolysaccharide-induced preeclampsia-like phenotypes via suppressing the inflammatory responses |
| Astragalosides | Preeclampsia | 1 | PM | 32924527 | 📋 | Astragaloside IV ameliorates preeclampsia-induced oxidative stress through Nrf2/HO-1 pathway in a rat model |
| Astragalosides | Uterine Leiomyomas | 1 | PM | 36139584 | 📋 | Astragaloside IV Inhibits the Proliferation of Human Uterine Leiomyomas by Targeting IDO1 |
